Celularity (CELU) Cash & Equivalents (2018 - 2026)
Celularity (CELU) posted Cash & Equivalents of $6.18 million for Q4 2025, up 736.7% from $738,000 a year earlier.
Powered by 
Analysis
Celularity (CELU) Cash & Equivalents (2018 - 2026) Analysis & Trends
Since Q4 2018, Celularity has reported Cash & Equivalents for 29 quarters.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -35.3% (FY2020 to FY2025).
- In prior years, Celularity's Cash & Equivalents was $738,000 in FY2024 (+225.1%), $227,000 in FY2023 (-98.4%), $13.97 million in FY2022 (-62.5%) and $37.24 million in FY2021 (-31.4%).
- The Q4 2025 figure stands as the highest quarterly Cash & Equivalents since Q1 2023.
- On a year-over-year basis, Cash & Equivalents increased in three of the last eight quarters, with growth averaging 92.3%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2025, with growth of 736.7%; the weakest was Q2 2021, with a decline of 100.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $120,000 (Q3 2025), $863,000 (Q2 2025) and $293,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | 368,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 368,000.00 |
| Dec 31, 2025 | 6.18 Mn |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 863,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | 738,000.00 |
| Sep 30, 2024 | 133,000.00 |
| Jun 30, 2024 | 467,000.00 |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 227,000.00 |
| Sep 30, 2023 | 273,000.00 |
| Jun 30, 2023 | 3.08 Mn |
| Mar 31, 2023 | 8.53 Mn |
| Dec 31, 2022 | 13.97 Mn |
| Sep 30, 2022 | 42.65 Mn |
| Jun 30, 2022 | 38.00 Mn |
| Mar 31, 2022 | 48.04 Mn |
| Dec 31, 2021 | 37.24 Mn |
| Sep 30, 2021 | 72.72 Mn |
| Jun 30, 2021 | 211.00 |
API Access
Celularity Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();